Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Size and Share: 

The global extracorporeal membrane oxygenation machine market size was valued at USD 559.68 Million in 2024. Looking forward, the market is projected to reach USD 913.93 Million by 2033, exhibiting a CAGR of 5.32% during 2025-2033. North America currently dominates the market, holding a significant market share of around 43.8% in 2024. The market is driven by the rising incidence of severe respiratory and cardiac conditions, alongside the increasing reliance on ECMO machines as life-saving support in critical care settings. Growing adoption of these systems for neonatal and pediatric applications, coupled with continuous advancements in oxygenators and circuit designs, is further augmenting the extracorporeal membrane oxygenation machine market share.

The global market is primarily driven by the rising prevalence of respiratory and cardiac disorders requiring advanced life-support systems. In line with this, the growing adoption of ECMO machines in critical care units to improve patient survival rates is also providing an impetus to the market. For instance, in 2023–2024, around 160 ECMO machines were sold in India, reflecting a sharp rise in adoption across healthcare institutions. In 2024, approximately 700 ECMO circuits were utilized. During the same year, about 54 centers were actively performing ECMO procedures nationwide. Moreover, the significant increase in cases of severe acute respiratory illnesses is also acting as a significant growth-inducing factor for the market. Besides this, the growing focus on improving neonatal and pediatric care is creating lucrative opportunities in the market, thereby contributing to the extracorporeal membrane oxygenation machine market growth.

To get more information on this market, Request Sample

The United States stands out as a key regional market, which is primarily driven by the strong presence of advanced hospital networks and critical care facilities. In line with this, the increasing healthcare expenditure across both public and private sectors is also providing an impetus to the market. A March 2024 peer-reviewed national survey of 274 adult ECMO centers found that 136 US hospitals responded: all offer ECMO, with several providing both veno-arterial (V-A) and veno-venous (V-V) ECMO. Of these, 50% managed <50 ECMO cases/year, 31% managed 50–100/year, and 19% handled >100 cases/year. Nearly half (46%) of centers had formal ECMO retrieval programs, many operating 24/7 and engaging in mobile/remote ECMO deployments. Moreover, the considerable rise in clinical research programs evaluating new applications of ECMO is also acting as a significant growth-inducing factor for the market. In addition to this, the expanding number of collaborations between medical device companies and research institutes are resulting in the faster development and commercialization of upgraded ECMO technologies.

Extracorporeal Membrane Oxygenation Machine Market Trends:

Rising Respiratory Burden Driving ECMO Adoption

The increasing global burden of respiratory illnesses is one of the most important factors driving demand for advanced life-support technologies such as ECMO. As such, respiratory tract infections remain a major burden, accounting for around 4 Million fatalities annually across all age groups and contributing to 20% of mortality in pediatric patients, as per industrial report. These conditions often overwhelm conventional ventilation methods, prompting clinicians to rely on ECMO as a rescue therapy to sustain patients through critical phases. Hospitals are expanding their critical care capacity, and many regions are investing in specialized ECMO programs to address this high mortality risk. With rising awareness among healthcare providers about the benefits of early ECMO initiation, utilization is growing steadily, further reinforcing its role in reducing respiratory-related mortality worldwide.

Cardiac and Age-Related Complications Expanding Demand

Cardiac complications are another key factor supporting ECMO adoption, particularly among vulnerable populations. As such, about 1 in 4 babies with a heart defect in the US have a critical heart defect. Furthermore, the rising geriatric population, which is more susceptible to chronic medical ailments, is providing an impetus to the market growth. This dual pressure from both ends of the age spectrum is significantly shaping demand, as per the extracorporeal membrane oxygenation machine market forecast. Pediatric patients with congenital heart defects often rely on ECMO to stabilize circulation before or after surgery, while older adults increasingly require it for cardiac failure cases associated with ischemic heart disease. This broadening scope of indications across young and elderly groups reflects the adaptability of ECMO systems. The market continues to expand as hospitals develop specialized teams capable of delivering ECMO care tailored to complex cardiovascular conditions.

Growing Geriatric Population Reinforcing Market Outlook

Demographic changes are resulting in the rise of long-term ECMO demand worldwide, which is one of the emerging extracorporeal membrane oxygenation machine market trends. The global geriatric (elderly) population is rapidly rising, with the number of people aged 60 and over projected to double from 1.1 billion in 2023 to 2.1 billion by 2050. Older individuals are far more likely to suffer from chronic respiratory and cardiovascular illnesses that can lead to acute life-threatening events requiring ECMO support. This growth in the elderly population base represents a massive pool of patients who may require advanced interventions. Healthcare systems are preparing for this demographic shift by expanding critical care resources, investing in training programs, and adopting new technologies to improve ECMO outcomes. With longevity on the rise, the need for advanced cardiopulmonary support systems will continue to strengthen, ensuring sustained growth in the ECMO market. 

Extracorporeal Membrane Oxygenation Machine Industry Segmentation: 

IMARC Group provides an analysis of the key trends in each segment of the global extracorporeal membrane oxygenation machine market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on component, modality, patient type, and application.

Analysis by Component: 

• Pumps 
• Oxygenator 
• Controllers 
• Cannula 
• Accessories 

Oxygenator stands as the largest component in 2024, holding around 35.4% of the market. This component is crucial in providing oxygenation to patients, mimicking the function of the lungs by oxygenating the blood outside the body during severe cardiac or respiratory failure. The oxygenator's dominance stems from its vital role in ensuring blood oxygenation, making it essential for all ECMO procedures. Its advancement in efficiency, biocompatibility, and cost-effectiveness has driven widespread adoption, particularly in critical care settings. As more hospitals invest in ECMO technology, the need for high-performing oxygenators is expected to continue growing, contributing significantly to market expansion and providing better patient outcomes.

Analysis by Modality: 

• Veno-Arterial 
• Veno-Venous 
• Arterio-Venous 

Veno-arterial leads the market with around 48.7% of market share in 2024. A ECMO is primarily used in patients suffering from severe cardiac failure, as it supports both heart and lung function by circulating oxygenated blood to the body. Its dominance in the market is due to the rising number of patients with heart failure, especially in emergency or post-cardiac surgery scenarios. As healthcare systems emphasize life-saving technologies, VA ECMO is vital in providing critical support during acute cardiac events. The modality’s efficiency in ensuring hemodynamic stability and oxygenation in severe cases drives its widespread adoption, supporting market growth in both developed and developing regions.

Analysis by Patient Type: 

• Neonates 
• Pediatric 
• Adult 

Adult leads the market in 2024, driven by the increasing prevalence of chronic diseases like heart failure, chronic obstructive pulmonary disease (COPD), and other conditions requiring ECMO support. The adult population often faces severe cardiac and respiratory complications, making ECMO a vital tool in their treatment. As adult patient numbers rise, particularly in aging populations and those with complex health issues, the demand for ECMO systems tailored to adult care continues to grow. Advances in ECMO technology, such as more efficient pumps and oxygenators, have improved the safety and effectiveness of these systems for adults, enhancing their use in critical care and contributing to market expansion.

Analysis by Application: 

• Respiratory 
• Cardiac 
• ECPR 

Respiratory leads the market with around 44.2% of the market share in 2024. This dominance is due to the increasing incidence of respiratory diseases such as severe pneumonia, acute respiratory distress syndrome (ARDS), and COVID-19, all of which often necessitate the use of ECMO for life support. Respiratory ECMO is critical in supporting oxygenation and ventilation in patients with severe respiratory failure, where conventional methods like mechanical ventilation are ineffective. The ongoing rise in respiratory illnesses, coupled with the technological improvements in ECMO devices, has driven the demand for respiratory ECMO. This segment’s growth is integral to the overall expansion of the ECMO market, as hospitals worldwide adopt these systems for treating critically ill patients

Regional Analysis: 

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa 

In 2024, North America accounted for the largest market share of around 43.8% . The rapid growth of healthcare infrastructure in countries like China, India, and Japan, combined with the increasing incidence of respiratory and cardiac diseases, has fueled the demand for ECMO machines. Additionally, government initiatives aimed at improving critical care services and supporting advanced medical technologies have made ECMO more accessible in the region. The expanding population, coupled with a growing emphasis on healthcare quality, is further propelling the adoption of ECMO devices. Asia-Pacific’s large and diverse healthcare market offers substantial growth opportunities, making it a dominant region in the ECMO industry’s global expansion.

Key Regional Takeaways: 

United States Extracorporeal Membrane Oxygenation Machine Market Analysis 

The United States accounts for 88.20% of the North America extracorporeal membrane oxygenation (ECMO) machine market. The market in the U.S. is experiencing notable growth, fueled by increased healthcare spending and the adoption of advanced life-support technologies in intensive care settings. The expanding number of organ transplant procedures and a growing emphasis on complex cardiopulmonary interventions are significantly contributing to demand. According to Organ Donor organization, 103,223 men, women, and children are currently on the national transplant waiting list, highlighting the critical need for temporary life-support systems like ECMO during pre- and post-transplant care. Rising awareness among healthcare professionals about the benefits of ECMO in managing severe cardiac and respiratory failure is further promoting its usage. Moreover, the integration of ECMO systems with real-time monitoring tools is streamlining clinical decision-making and improving patient outcomes. The presence of skilled medical personnel and the rising frequency of continuing medical education programs are enhancing the operational efficiency and uptake of these machines. The trend of utilizing ECMO during extended surgical procedures is gaining momentum, especially in tertiary care hospitals. Healthcare institutions and research organizations are collaborating to accelerate innovation in ECMO technology, enhancing their role in critical care environments and advanced life-support systems. 

Europe Extracorporeal Membrane Oxygenation Machine Market Analysis 

In Europe, the ECMO machine market is progressing steadily due to the growing geriatric population and the corresponding rise in age-related cardiopulmonary conditions. The region’s well-established healthcare infrastructure is enabling greater access to critical care therapies, including ECMO. As reported by WHO, chronic respiratory diseases (CRDs) affect approximately 81.7 Million people in the European Region alone, underscoring the growing burden of respiratory conditions that can benefit from ECMO intervention. Emphasis on reducing ICU mortality rates through cutting-edge interventions is encouraging hospitals to invest in high-performance ECMO systems. The increasing deployment of mobile ECMO units for patient transfers is another emerging trend supporting market expansion. Furthermore, regional training initiatives aimed at enhancing clinical competency in ECMO usage are resulting in broader adoption across medical institutions. Advancements in perfusion technology and data integration are improving workflows and enhancing user experience and treatment outcomes. Multidisciplinary teams, evidence-based practices, and clinical trials support ECMO utilization. 

Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Analysis 

The Asia Pacific ECMO machine market is witnessing rapid growth, driven by increasing investments in healthcare infrastructure and the rise of specialized critical care units. According to the India Brand Equity Foundation (IBEF), India’s healthcare market, valued at USD 110 Billion in FY16, is projected to reach USD 638 Billion by FY25, reflecting a broader regional trend of healthcare modernization that supports ECMO adoption. Technological advancements, such as compact ECMO devices tailored for pediatric and neonatal use, are expanding the scope of applications across diverse demographics. The surge in medical tourism and the region’s focus on enhancing intensive care capabilities are also spurring demand. Additionally, the rising incidence of acute respiratory syndromes is prompting healthcare providers to adopt ECMO as a frontline intervention. The integration of ECMO training into medical curricula and simulation-based workshops is building clinical confidence and operational proficiency, further accelerating market penetration. 

Latin America Extracorporeal Membrane Oxygenation Machine Market Analysis 

In Latin America, the ECMO machine market is advancing due to the increasing availability of specialized cardiovascular and pulmonary care services. Industry reports that in Brazil alone, social security benefits for cardiovascular diseases amount to nearly USD 20 Million annually, while the broader economic burden is around USD 2 Billion, projected to reach USD 12 Billion in the next five years, underscoring the urgency of adopting effective life-support solutions such as ECMO. The rise in public and private sector collaborations aimed at upgrading critical care units is creating favorable conditions for ECMO adoption. Academic partnerships supporting knowledge exchange and clinician training are also facilitating technology diffusion. Furthermore, the region is witnessing a growing trend of incorporating ECMO in pediatric intensive care settings, expanding its clinical application. 

Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Analysis 

The ECMO machine market in the Middle East and Africa is growing steadily, supported by the increasing emphasis on emergency preparedness and critical care readiness. As per the U.S.-Saudi Business Council, the government aims to raise the private sector’s share in healthcare to 65% of total services by 2030, marking a significant shift from current public-sector dominance and fostering demand for advanced life-support technologies like ECMO. Rising demand for advanced cardiopulmonary support during complex surgeries and trauma cases is elevating the importance of ECMO systems. Regional healthcare authorities are training medical teams for effective ECMO deployment and developing high-acuity intensive care units to improve critical care outcomes and encourage greater use of ECMO technologies. 

Competitive Landscape: 

Key players in the market are actively investing in research and development to introduce technologically advanced ECMO machines with improved efficiency, portability, and safety features. They are focusing on expanding product portfolios with next-generation oxygenators, user-friendly interfaces, and systems designed for both adult and pediatric applications. In addition, strategic collaborations with healthcare institutions are enabling faster clinical adoption and broader awareness of ECMO therapy. Companies are also strengthening their global distribution networks, ensuring timely access to devices in high-demand regions. Furthermore, regulatory approvals and supportive reimbursement strategies are being leveraged to accelerate commercialization, while targeted training programs for healthcare professionals are helping improve operational expertise, collectively driving greater adoption and contributing to overall positive extracorporeal membrane oxygenation machine market outlook.

The report provides a comprehensive analysis of the competitive landscape in the extracorporeal membrane oxygenation machine market with detailed profiles of all major companies, including: 

• Abbott Laboratories 
• ALung Technologies Inc. 
• Braile Biomedical 
• Eurosets 
• LivaNova PLC
• Medtronic 
• MicroPort Scientific Corporation 
• Nipro Medical Corporation 
• Origen Biomedical, Inc. 
• Terumo Corporation
• Xenios AG 

Latest News and Developments: 

• June 2025: UT Health East Texas deployed a specialized critical care ambulance equipped for neonatal and ECMO patient transport. The unit included advanced life-support technologies and a trained team, extending critical care access across the region. It enabled safe, hospital-level treatment during transit, enhancing survival chances for critically ill patients. 
• May 2025: InflaRx halted its Phase 3 trial of vilobelimab in pyoderma gangrenosum after interim analysis showed futility. The company remained committed to anti-inflammatory innovations, including ECMO-related treatments. Vilobelimab, authorized for emergency COVID-19 use in ECMO-supported patients, continued under FDA and EMA oversight for acute respiratory distress syndrome. 
• May 2025: Manipal Hospital Vijayawada introduced ECMO services for severe cardiac and respiratory failure cases. The technology functioned as a heart-lung bypass system, supporting recovery or transplant readiness. Its implementation required a multidisciplinary team, underscoring the hospital’s commitment to advanced, life-saving interventions in Andhra Pradesh’s evolving critical care landscape. 
• March 2025: Hemab Therapeutics began a Phase 1/2 trial for HMB-002, a subcutaneous antibody designed for all types of von Willebrand disease. While unrelated to ECMO directly, the advancement highlighted ongoing innovation in life-threatening conditions. Future data could influence adjunct therapies in coagulopathies seen during ECMO-supported critical care cases. 

Extracorporeal Membrane Oxygenation Machine Market Report Scope: 

Key Benefits for Stakeholders: 

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the extracorporeal membrane oxygenation machine market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global extracorporeal membrane oxygenation machine market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the keyword industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.